A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic Malignancies
Ossium Health, Inc.
Ossium Health, Inc.
National Institutes of Health Clinical Center (CC)
Ohio State University Comprehensive Cancer Center
Incyte Corporation
City of Hope Medical Center
Ohio State University Comprehensive Cancer Center
Institute of Hematology & Blood Diseases Hospital, China
UNC Lineberger Comprehensive Cancer Center
Mayo Clinic
Mayo Clinic
Ohio State University Comprehensive Cancer Center
Barbara Ann Karmanos Cancer Institute
UNC Lineberger Comprehensive Cancer Center
UNC Lineberger Comprehensive Cancer Center
City of Hope Medical Center
Memorial Sloan Kettering Cancer Center
City of Hope Medical Center
Bio-Path Holdings, Inc.
Daiichi Sankyo
Mundipharma Research Limited
Kyowa Kirin Co., Ltd.
City of Hope Medical Center
Stanford University
Stanford University
University of Nebraska
University of Nebraska
Children's Oncology Group
University of Nebraska
Eastern Cooperative Oncology Group
Atara Biotherapeutics
Karyopharm Therapeutics Inc
Columbia University
Thomas Jefferson University
Roswell Park Cancer Institute
Memorial Sloan Kettering Cancer Center
National Institutes of Health Clinical Center (CC)
Alexion Pharmaceuticals, Inc.
Northwestern University
Roswell Park Cancer Institute
AbbVie
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
University of Michigan Rogel Cancer Center
Barbara Ann Karmanos Cancer Institute
miRagen Therapeutics, Inc.
M.D. Anderson Cancer Center
Roswell Park Cancer Institute
Jonsson Comprehensive Cancer Center
Jonsson Comprehensive Cancer Center
Jonsson Comprehensive Cancer Center